Madrigal Pharmaceuticals, Inc. Common Stock

MDGLNASDAQ • USD
424.12 USD
↘ 3.27 (0.77%)🟢LIVE (AS OF 02:00 PM EST)
🟢Market: OPEN

Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently trading at $424.12. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$424.08
High?$449.09
Low?$418.01
Prev. Close?$427.39
Volume?202.7K
Avg. Volume?497.3K
VWAP?$423.76
Rel. Volume?0.41x
Bid / Ask
Bid?$422.47 × 40
Ask?$449.40 × 40
Spread?$26.93
Midpoint?$435.94
Valuation & Ratios
Market Cap?9.9B
Shares Out?23.2M
Float?14.9M
Float %?64.6%
P/E Ratio?N/A
P/B Ratio?15.84
EPS?-$6.69
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Employees
915
Market Cap
9.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2007-02-06
Address
1001 CONSHOHOCKEN STATE ROAD
WEST CONSHOHOCKEN, PA
Phone: (267) 824-2827
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
100
Momentum?
91
Short Sent.?
54
Piotroski F-Score?4/9Mixed
Altman Z-Score?6.67Safe
Confidence?63%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?14.33%High
Short Interest?2.1M
Days to Cover?7.6
Free Float14.9M
Avg Daily Volume279.6K
Settlement Date2026-10-30
Financial Health
Current Ratio?3.05Strong
Quick Ratio?2.78Strong
Cash Ratio?1.13Strong
Debt/Equity?0.54Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
11
15.84HIGH▾
P/S?
Peers
100
S&P
17
6.95FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-64.6CHEAP▾
EV/Sales?
Peers
100
S&P
21
6.83HIGH▾
Returns & Efficiency
ROE?
S&P
7
-24.8%WEAK▾
ROA?
S&P
3
-10.8%WEAK▾
Cash Flow & Enterprise
FCF?$-168650000
Enterprise Value?$9.8B
Fundamentals ratios updated end of day